Abstract: The present invention relates to a process comprising the steps of reacting a substituted epoxide, and preferably a silicone containing substituted epoxide with at least one lithium acrylic acid salt, at least one acrylic acid and optionally at least one inhibitor at a temperature above about 60° C. to form a substituted hydroxy acrylate.

Abstract: The present invention relates to a process for the synthesis of aryloxypropylamine and heteroaryloxypropylamine of formula I: where: A is aryl or heteroaryl, where the aryl is preferably a phenyl, optionally substituted, selected from benzyl and tolyl and the heteroaryl is preferably thiophenyl; Y is an aryl, preferably phenyl, a substituted phenyl or a naphthyl, where the substituted phenyl is preferably selected from tolyl, trihalomethyltolyl and alkoxytolyl, starting from a suitable amino alcohol of formula II:

Abstract: The object of the invention is a method for preparing silanes of the general formula (1) RaHbSiCl4?a?b (1), wherein mixtures of silanes of the general formulas (2) and (3) RcSiCl4?c (2), RdHeSiCl4?d?e, where R indicates an alkyl radical with 1 to 6 carbon atoms, a indicates the values 1, 2 or 3, b indicates the values 0 or 1, c indicates the values 1, 2, 3 or 4, d indicates the values 0, 1 or 2 and e indicates the values 0, 1 or 2, are reacted in the presence of an aluminum oxide catalyst comprising 1 to 10 parts by weight of aluminum chloride and 0.5 to 10 parts by weight of a metal oxide selected from magnesium oxide, copper oxide, zinc oxide and mixtures thereof to 100 parts by weight of aluminum oxide.

Abstract: To attain an organic electroluminescence device having a long lifetime and high luminous efficiency, and is capable of emitting blue light having a high color purity, and an aromatic amine derivative for realizing the device, the present invention provides an aromatic amine derivative having a specific structure, and an organic electroluminescence device including an organic thin film layer composed of one or more layers including at least a light emitting layer and interposed between a cathode and an anode, in which at least one layer of the organic thin film layer contains the aromatic amine derivative alone or as a component of a mixture.

Abstract: The invention relates to a method for producing oligoaminosilanes of the general formula (I) SinY2n+2, wherein oligohalosilanes of the general formula (II) SinX2n+2 are reacted with primary amines of the general formula (III) R—NH2 in hydrocarbons as solvents, wherein X is selected from among chlorine, bromine, and iodine, Y is a halogen, hydrogen, or R—NH, R is a hydrocarbon group having 1 to 20 carbon atoms, and n is values from 1 to 20, with the stipulation that at most 35 mol % of the groups Y is a hydrogen and at most 15 mol % of the groups Y is a halogen, wherein activated carbon is added to the reaction mixture. The invention further relates to a method for stabilizing the oligoaminosilanes of the general formula (I), wherein the oligoaminosilanes are treated with activated carbon.

Abstract: The invention relates to novel compounds of the formula (I) in which X, Y, Z, A, B and G have the meanings given above, to a plurality of processes and intermediates for their preparation and to their use as pesticides and/or herbicides. Moreover, the invention relates to selective herbicidal compositions comprising, firstly, the phenyl-substituted bicyclooctane-1,3-dione derivates 33 and, secondly, a crop plant compatibility-improving compound. The present invention furthermore relates to increasing the activity of crop protection compositions comprising in particular phenyl-substituted bicyclooctane-1,3-dione derivates by adding ammonium salts or phosphonium salts and, if appropriate, penetrants, to the corresponding compositions, to processes for their preparation and to their use in crop protection as insecticides and/or acaricides and/or for preventing unwanted plant growth.

Abstract: An object of the present invention is to provide a process allowing long-term, stable production of isocyanates at a high yield without the various problems found in the prior art during production of isocyanates without using phosgene. The present invention discloses a process for producing an isocyanate by subjecting a carbamic acid ester to a decomposition reaction in the presence of a compound having an active proton and a carbonic acid derivative.

Abstract: The present invention relates to a novel sulfone hybrid precursor, to the synthesis method thereof, and to the uses thereof, particularly for preparing proton-exchanging electrolyte membranes as the functional hybrid charge in a host structure; for the manufacture of functional hybrid nanoparticles by sol-gel polymerization; for the use as a fluidifying agent; for the production of surface coverings through chemical grafting by means of sol-gel polymerization; for the use as a hygroscopic agent; and for the use as a bonding or structuring agent.

Abstract: There is provided a process capable of preventing the adhesion of a catalyst to an evaporator in a step of separating a chlorophosphite as a target substance from a reaction liquid by evaporation. The process includes a first step of allowing phosphorus trichloride and a phosphorous acid triester represented by (RO)3P to react in the presence of a catalyst having a viscosity at 80° C. of 100 mPa·s or lower to produce a chlorophosphite represented by RO(R?)PCl, and a second step of vaporizing a reaction liquid containing the chlorophosphite obtained in the first step, in a short time, to separate the catalyst.

Abstract: To provide a gelling agent containing a fluoroalkyl derivative, a small amount of which can gelatinize or solidify various organic solvents. The gelling agent for organic liquids contains a fluoroalkyl derivative represented by the following formula: wherein each of m, n and x is a positive integer.

Abstract: An amino acid-modified organopolysiloxane is provided. It has an amino acid derivative bonded to at least one silicon atom of the organopolysiloxane segment constituting the backbone of the organopolysiloxane via an amide bond represented by the following general formula (1): wherein X and Y are independently a C1-10 divalent hydrocarbon group; m is an integer of 0 to 4; Ra is hydrogen atom, a monovalent hydrocarbon group containing 1 to 4 carbon atoms, or an organic group represented by the following general formula (2): (wherein Rb is hydrogen atom, a C1-7 monovalent hydrocarbon group, an alkaline metal, or an alkaline earth metal, and Rc is independently hydrogen atom, hydroxy group, or a C1-10 monovalent hydrocarbon group optionally containing oxygen atom, sulfur atom, or nitrogen atom); and Z is an organic group represented by the general formula (2).

Abstract: The invention relates to a process for the production of diols with a special structure which are characterized by formula (I). These diols are substances which, besides two OH groups, contain a C?C double bond so that they are suitable as monomers for the production of polymers. The process comprises hydrolyzing a corresponding cyclic precursor in aqueous medium in the presence of an acid dissolved in that medium, the hydrolysis being accompanied by the elimination of a carbonyl compound, and subsequently neutralizing the acid present in the reaction mixture with a base, the base having a pKb value above 0.18 and preferably above 3.0 and being present in heterogeneous form.

Abstract: A hydrophilic vehicle-based dual controlled-release matrix system, suitable for encapsulation in hard or soft capsules, has been developed. The matrix is in the form of a solution or a suspension, which allows for easier formulation of low dose compounds. The matrix includes two rate controlling barriers for the controlled release of one or more pharmaceutically active agents. The primary rate controlling barrier includes a hydrophilic vehicle. The primary rate controlling barrier can further comprise one or more solvents which are miscible with the hydrophilic vehicle. The secondary rate controlling barrier includes a hydrogel-forming polymeric material dissolved or dispersed in the hydrophilic vehicle. The presence of the hydrogel-forming polymeric material makes extraction of the drug from the dosage form more difficult. This feature could be beneficial in preventing or minimizing the misuse of dosage forms which contain drugs which are prone to abuse.

Abstract: Disclosed is crystalline R(+)-N-propargyl-1-aminoindan and racemic N-propargyl-1-aminoindan characterized by colorless crystals a pharmaceutical composition comprising the same, and the process for the manufacture and the validation thereof. Also disclosed is pure liquid R(+)-N-propargyl-1-aminoindan and a pharmaceutical composition comprising the same, and the process for the manufacture thereof.

Abstract: The present invention provides a process for preparing 3-(methylthio)propanal which can sufficiently decrease the production of high-boiling impurities as a by-product. The process comprises reacting acrolein and methyl mercaptan in the presence of Allylamines (I), Triallylamines (II), and preferably an optional organic acid. The preferred amount of Allylamines (I) is 0.001 to 0.50 mol per 1 mol of Triallylamines (II).

Abstract: Methods of applying cyclopropene amine derivatives and compositions thereof to inhibit ethylene receptors in plants and plant material are disclosed. Methods include applying to the plant an effective ethylene response-inhibiting amount of at least one cyclopropene amine compound or composition thereof. Cyclopropene amine compounds, enantiomers, stereoisomers or salts thereof are also provided.

Abstract: A hair treatment composition comprising an acrylic pressure sensitive adhesive.

Abstract: A multi-step process for preparing 2,3,3,3-tetrafluoro-1-propene comprising the steps of (a) contacting a starting material comprising 2-chloro-3,3,3-trifluoro-1-propene with hydrogen fluoride in the presence of activated first catalyst selected from the group consisting of antimony-halides, iron-halides, titanium halides, and tin-halides, to produce an intermediate composition; and (b) contacting said intermediate composition with a second catalyst of activated carbon to produce a final product comprising 2,3,3,3-tetrafluoro-1-propene.

Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.

Abstract: An unsaturated hydrogen-containing fluoroolefin compound is obtained by bringing an unsaturated fluorine-containing halogen compound into contact with 0.1 to 3 molar equivalents of hydrogen relative to the unsaturated fluorine-containing halogen compound in a vapor phase in the presence of a supported palladium catalyst in which an amount of supported palladium is 0.1% by weight to 2.5% by weight.